ATRA vs QRVO · rev $1.1M vs P/E 27, rev $3.68B
Atara Biotherapeutics Inc (ATRA) versus Qorvo Inc (QRVO) — a side-by-side from cached financials, not a winner call.
Atara Biotherapeutics Inc (ATRA) is a biotechnology company listed on NASDAQ.
Qorvo Inc (QRVO) is a semiconductors company listed on NASDAQ.
Latest reported ATRA revenue for 2026-06-30 was $1.1M. Net income was -$9.0M. ATRA currently screens at market cap $87.1M.
Latest reported QRVO revenue for 2026-03-28 was $3.68B. Net income was $339.0M. Revenue was down 1.1% from 2025-03-29 to 2026-03-28. QRVO currently screens at market cap $8.54B and trailing P/E 26.8.
ATRA currently screens at market cap $87.1M. QRVO currently screens at market cap $8.54B and trailing P/E 26.8.
Not investment advice. Open the ATRA and QRVO stock pages for the full models.
Not investment advice.